Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 34 non-cytoplasmic 35 54 transmembrane 55 88 cytoplasmic 89 111 transmembrane 112 131 non-cytoplasmic 132 161 transmembrane 162 172 cytoplasmic 173 197 transmembrane 198 207 non-cytoplasmic 208 233 transmembrane 234 254 cytoplasmic 255 277 transmembrane 278 282 non-cytoplasmic 283 302 transmembrane 303 313 cytoplasmic 314 334 transmembrane 335 353 non-cytoplasmic 354 372 transmembrane 373 377 cytoplasmic 378 397 transmembrane 398 406 non-cytoplasmic 407 434 transmembrane 435 446 cytoplasmic 447 476 transmembrane 477 482 non-cytoplasmic
Input: >3610014 MFLLEALGQFMTLNEFAVLAMFLVFIYLLFRGIPVAYALVGVSLIFALVAEIFLDPNRAA FRDIIEFDRTGIDYQRLQVLSGRLFGNIVKNPVLVALPMFIFMGLMLDQSGVAQRMMHSM QKLFGGLRGGLSLTVMLIGIILAASTGVIGASVTLLGVMALPAMMQQNYSKPIATGTIAS AGTLGILIPPSIMLVIMSDQLAISLGDLFMGALFPGLILGALYIIFIIAYGLINPKAMPA PPQTDEVGWDVVKDVLLAVVPPMFLILLVLGSIFAGFATPTEASGLGALGATLLALANGR LNFKVLKEVSRSTLNTSGYIVGIFLAANFFALVLRRYGGDEIIQGYVLSTFSDPYMIVLF ILFIIFLLGFLLDWIEITIIIMPLMLPIIVGLDLAVPGFDQVRDPAVVWFAILVAVTLQT SFLTPPVGFALFYLKGVCPPGVSLGHIYKGIIPFVMLQLLGLFIVFQFPALTTWLPAIAY AD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server